France Sepsis Diagnostics Market Size & Outlook, 2022-2030

The sepsis diagnostics market in France is expected to reach a projected revenue of US$ 72.6 million by 2030. A compound annual growth rate of 7.4% is expected of France sepsis diagnostics market from 2023 to 2030.
Revenue, 2022 (US$M)
$41.1
Forecast, 2030 (US$M)
$72.6
CAGR, 2023 - 2030
7.4%
Report Coverage
France

France sepsis diagnostics market highlights

  • The France sepsis diagnostics market generated a revenue of USD 41.1 million in 2022 and is expected to reach USD 72.6 million by 2030.
  • The France market is expected to grow at a CAGR of 7.4% from 2023 to 2030.
  • In terms of segment, blood culture media was the largest revenue generating product in 2022.
  • Assay Kits & Reagents is the most lucrative product segment registering the fastest growth during the forecast period.


Sepsis diagnostics market data book summary

Market revenue in 2022USD 41.1 million
Market revenue in 2030USD 72.6 million
Growth rate7.4% (CAGR from 2022 to 2030)
Largest segmentBlood culture media
Fastest growing segmentAssay Kits & Reagents
Historical data2018 - 2021
Base year2022
Forecast period2023 - 2030
Quantitative unitsRevenue in USD million
Market segmentationInstruments, Blood Culture Media, Assay Kits & Reagents, Software
Key market players worldwideBD, BioMerieux SA, Thermo Fisher Scientific Inc, Danaher Corp, Roche Holding AG ADR, Luminex, Koninklijke Philips NV, Bruker Corp, Cepheid, Immunexpress


Other key industry trends

  • In terms of revenue, France accounted for 4.1% of the global sepsis diagnostics market in 2022.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Europe, Germany sepsis diagnostics market is projected to lead the regional market in terms of revenue in 2030.
  • UK is the fastest growing regional market in Europe and is projected to reach USD 82.5 million by 2030.

Blood culture media was the largest segment with a revenue share of 38.93% in 2022. Horizon Databook has segmented the France sepsis diagnostics market based on instruments, blood culture media, assay kits & reagents, software covering the revenue growth of each sub-segment from 2018 to 2030.


According to the European Sepsis Alliance, sepsis is estimated to be responsible for nearly 57,000 deaths in France each year. This high mortality rate highlights the critical need for enhanced sepsis diagnosis and treatment protocols in France.

Improving early detection and intervention can potentially save lives and reduce the overall economic impact of sepsis on the healthcare system. According to an article published by the National Institutes of Health in August 2023, sepsis imposes a significant burden on European health systems and society.

These figures highlight the substantial economic impact of sepsis on healthcare systems, emphasizing the urgent need for effective diagnostic and treatment strategies to manage this life threatening condition & mitigate its financial strain.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Sepsis Diagnostics Market Companies

Name Profile # Employees HQ Website

France sepsis diagnostics market size, by product, 2018-2030 (US$M)

France Sepsis Diagnostics Market Outlook Share, 2022 & 2030 (US$M)

France sepsis diagnostics market size, by product, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more